Entity Selection: LLCs, C-Corps, and S-Corps
The choice of business entity dictates how a cannabis operation is taxed, how liability is distributed, and how capital can be raised. Because cannabis remains federally illegal, standard corporate protections are frequently tested, making entity selection a critical first step.
- Limited Liability Companies (LLCs): LLCs are the most common entity choice for early-stage cannabis startups due to their operational flexibility and pass-through taxation. However, pass-through taxation means that the severe tax burdens of IRC 280E flow directly to the individual members' personal tax returns. This can result in phantom income, where members owe taxes on money the business generated but did not distribute.
- C-Corporations (C-Corps): C-Corps are taxed separately from their owners, trapping the 280E tax liability at the corporate level and shielding individual shareholders' personal returns. This structure is highly preferred by institutional investors and venture capital firms. While C-Corps face double taxation (the corporation is taxed on profits, and shareholders are taxed on dividends), the ability to isolate 280E liability often outweighs this drawback for large-scale operations.
- S-Corporations (S-Corps): S-Corps offer pass-through taxation like LLCs but require strict adherence to corporate formalities and limit the number and type of shareholders (e.g., no foreign investors or corporate shareholders). Due to the complexities of 280E and the frequent need to raise capital from diverse sources, S-Corps are rarely the optimal choice for plant-touching cannabis businesses.
The Elephant in the Room: IRC Section 280E
Internal Revenue Code Section 280E is the single largest financial hurdle for state-legal cannabis businesses. Enacted in 1982, the statute prohibits businesses that traffic in Schedule I or II controlled substances from deducting ordinary and necessary business expenses from their gross income.
Under 280E, a cannabis dispensary or cultivator cannot deduct standard operational costs such as:
- Employee payroll and benefits (for sales and administrative staff)
- Commercial rent and utility payments for retail space
- Marketing, advertising, and legal fees
- Insurance premiums
The only allowable deduction is the Cost of Goods Sold (COGS) - the direct costs attributable to the production or purchase of the cannabis inventory. Because operators are taxed on their gross margin rather than their net profit, effective federal tax rates frequently exceed 70 percent, severely restricting cash flow and profitability.
The Impact of Schedule III Rescheduling on 280E
The regulatory environment shifted dramatically with the December 18, 2025, Executive Order directing the Department of Justice to expedite the rescheduling of cannabis to Schedule III. Because IRC 280E explicitly applies only to Schedule I and II substances, a finalized Schedule III designation eliminates this punitive tax burden.
Once the DEA finalizes the administrative rulemaking process, cannabis operators will be permitted to claim standard business deductions under IRC Section 162. This transition requires operators to fundamentally restructure their accounting practices, separating COGS from SG&A (Selling, General, and Administrative) expenses to maximize their newly available deductions.
IRC 280E Transition Matrix
The following matrix illustrates the deterministic shift in tax liability based on the transition from Schedule I to Schedule III.
| Expense Category | Current Reality (Schedule I / 280E Active) | Post-Rescheduling (Schedule III / 280E Inactive) | | :--- | :--- | :--- | | Wholesale Inventory Purchases | Deductible (COGS) | Deductible (COGS) | | Cultivation Equipment & Soil | Deductible (COGS) | Deductible (COGS) | | Retail Budtender Payroll | Non-Deductible | Deductible (SG&A) | | Dispensary Commercial Rent | Non-Deductible | Deductible (SG&A) | | Marketing & Advertising | Non-Deductible | Deductible (SG&A) | | Legal & Accounting Fees | Non-Deductible | Deductible (SG&A) |
Holding Companies and Asset Protection
To isolate risk and optimize tax strategies, sophisticated cannabis operators utilize a holding company structure. This involves creating a parent company (the holding company) that owns the intellectual property, real estate, and equipment, while a separate subsidiary entity (the operating company) holds the state cannabis license and handles the plant-touching activities.
The holding company leases the real estate and licenses the intellectual property (such as trademarks and standard operating procedures) to the operating company. This structure provides several deterministic advantages:
- Asset Isolation: If the operating company faces a regulatory fine, license revocation, or federal civil asset forfeiture, the assets held by the parent company are insulated from the immediate liability.
- Tax Optimization: The holding company, which does not traffic in controlled substances, can deduct its ordinary business expenses under IRC Section 162, mitigating the overall impact of 280E on the enterprise prior to Schedule III implementation.
- Investment Vehicle: Investors can inject capital into the holding company rather than the plant-touching operating company, reducing their direct exposure to federal prohibition risks.
To ensure this structure withstands regulatory and IRS scrutiny, the relationship between the holding company and the operating subsidiary must be formalized through arm's-length agreements. This includes drafting robust Intellectual Property (IP) Licensing Agreements for the use of the brand name and SOPs, as well as Commercial Equipment Leases for cultivation lights and extraction machinery. These agreements must reflect fair market value; if the IRS determines the holding company is artificially inflating lease rates to siphon profits from the operating company and evade 280E, they will recharacterize the transactions and assess massive penalties.